drugset / Trial / NCT00826930
Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to evaluate the impact of Trans Sodium Crocetinate (TSC) on oxygen levels in brain tumor tissue in patients with high grade glioma. The proposed clinical indication for TSC is a radiation sensitizer for the treatment of cancerous tumors.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trans Sodium Crocetinate | Other / unclassified | 0.5 mg/kg | Intravenous |
| Subject | Trans Sodium Crocetinate | Other / unclassified | 0.75 mg/kg | Intravenous |
| Subject | Trans Sodium Crocetinate | Other / unclassified | 1 mg/kg | Intravenous |